Adjuvant Belzutifan-Pembrolizumab Significantly Boosts DFS in Kidney Cancer

(MedPage Today) — SAN FRANCISCO — The adjuvant combination of pembrolizumab (Keytruda) and belzutifan (Welireg) significantly improved disease-free survival (DFS) in patients with clear cell renal cell carcinoma (ccRCC) after nephrectomy versus…

Source link : https://www.medpagetoday.com/meetingcoverage/mgucs/120099

Author :

Publish date : 2026-02-28 22:17:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

Adjuvant Belzutifan-Pembrolizumab Significantly Boosts DFS in Kidney Cancer

Quiz Time: Which Doctor Group Broke Ties With CDC’s Vaccine Panel?

My Dad’s Stroke Changed How I Viewed the Risks of Hypertension

Related Posts

Extinct relative of koalas discovered in Western Australia

Cruise ship with hantavirus outbreak to sail to Canary Islands

What a U.S. Study Found About the Shingles Vaccine and Dementia

Is Chronic Vulvar Pain Being Missed, Undertreated in Black and Hispanic Patients?

RFK Jr. Launches Effort to Encourage Antidepressant Deprescribing

Study Looks at GLP-1 Use in Pregnancy and Gestational Weight Gain

Extinct relative of koalas discovered in Western Australia

Cruise ship with hantavirus outbreak to sail to Canary Islands

What a U.S. Study Found About the Shingles Vaccine and Dementia

Is Chronic Vulvar Pain Being Missed, Undertreated in Black and Hispanic Patients?

RFK Jr. Launches Effort to Encourage Antidepressant Deprescribing

Study Looks at GLP-1 Use in Pregnancy and Gestational Weight Gain

Hospital Shootings Became More Common Over 25 Years

Regular Cannabis Use Linked to Symptoms of Menopause

Categories

Archives